Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ELUTIA INC.AZYO · Entity 7342 | CHIEF MEDICAL OFFICER | September 08, 2022 | September 12, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ELUTIA INC.
Report date September 08, 2022 · Filed September 12, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 20,093 |
Reported balance
After 2022-09-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-09-08 · Exercise / conversion · Acquired 14,758 · Balance 20,093 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units. F2: Includes one share of the Issuer's Class A Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan. |
| Class A Common StockSEC Table I · non-derivative | Direct | 14,989 |
Reported balance
After 2022-09-08 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2022-09-08 · Tax withholding · Disposed 5,104 · Balance 14,989 F3: Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-09-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-09-08 · Exercise / conversion · Disposed 14,758 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units. F4: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.
F2: Includes one share of the Issuer's Class A Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.
F3: Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
F4: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 08, 2022 Filed Sep 12, 2022 21:01 UTC | ELUTIA INC. AZYO · Entity 7342 | Exercise / conversionRestricted Stock Units · Derivative | 14,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-009536 · form4-09122022_020937.xml · derivative · entry 3 Riebman Jerome · CIK 0001825821 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 14,758 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units. F4 · derivative.exercise_date: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022. F4 · derivative.expiration_date: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 21:01 UTC | ELUTIA INC. AZYO · Entity 7342 | Tax withholdingClass A Common Stock | 5,104 | $7.30 | $37,259.20 |
DisclosureSEC source: 0001415889-22-009536 · form4-09122022_020937.xml · nonDerivative · entry 2 Riebman Jerome · CIK 0001825821 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,989 F3 · shares: Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 21:01 UTC | ELUTIA INC. AZYO · Entity 7342 | Exercise / conversionClass A Common Stock | 14,758 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-009536 · form4-09122022_020937.xml · nonDerivative · entry 1 Riebman Jerome · CIK 0001825821 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,093 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units. F2 · balance_after: Includes one share of the Issuer's Class A Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 01:36 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantRestricted Stock Units · Derivative | 14,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002862 · form4-03102022_050332.xml · derivative · entry 5 Riebman Jerome · CIK 0001825821 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,758 Underlying: Class A Common Stock · 14,758 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock. F7 · derivative.exercise_date: The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date. F7 · derivative.expiration_date: The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 01:36 UTC | ELUTIA INC. AZYO · Entity 7342 | Exercise / conversionRestricted Stock Units · Derivative | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002862 · form4-03102022_050332.xml · derivative · entry 4 Riebman Jerome · CIK 0001825821 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,343 Underlying: Class A Common Stock · 782 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis. F6 · derivative.exercise_date: On March 8, 2021, the Reporting Person was granted 3,125 restricted stock units, vesting in four substantially equal annual installments beginning on March 8, 2022. F6 · derivative.expiration_date: On March 8, 2021, the Reporting Person was granted 3,125 restricted stock units, vesting in four substantially equal annual installments beginning on March 8, 2022. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 01:36 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantRestricted Stock Units · Derivative | 8,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002862 · form4-03102022_050332.xml · derivative · entry 3 Riebman Jerome · CIK 0001825821 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,700 Underlying: Class A Common Stock · 8,700 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock. F5 · derivative.exercise_date: The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024. F5 · derivative.expiration_date: The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 01:36 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $5.08 | $0.00 |
DisclosureSEC source: 0001415889-22-002862 · form4-03102022_050332.xml · derivative · entry 2 Riebman Jerome · CIK 0001825821 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 Underlying: Class A Common Stock · 31,000 shares Expires 2032-03-08 F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 8, 2023 and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2026. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 01:36 UTC | ELUTIA INC. AZYO · Entity 7342 | Exercise / conversionClass A Common Stock | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002862 · form4-03102022_050332.xml · nonDerivative · entry 1 Riebman Jerome · CIK 0001825821 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis. F2 · balance_after: Includes 4,552 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 21:18 UTC | ELUTIA INC. AYZO · Entity 7342 | GrantRESTRICTED STOCK UNITS · Derivative | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-034460 · tm219212-3_4seq1.xml · derivative · entry 2 Riebman Jerome · CIK 0001825821 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,125 Underlying: CLASS A COMMON STOCK · 3,125 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in 4 substantially equal annual installments beginning on March 8, 2022 and have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest in 4 substantially equal annual installments beginning on March 8, 2022 and have no expiration date. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 21:18 UTC | ELUTIA INC. AYZO · Entity 7342 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 18,750 | $0.00 Strike: $14.53 | $0.00 |
DisclosureSEC source: 0001104659-21-034460 · tm219212-3_4seq1.xml · derivative · entry 1 Riebman Jerome · CIK 0001825821 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: CLASS A COMMON STOCK · 18,750 shares Expires 2031-03-08 F1 · derivative.exercise_date: This option vests as to 25% of the shares on March 8, 2022, and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2025. Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 00:28 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantRestricted Stock Units · Derivative | 10,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-113580 · a4.xml · derivative · entry 2 Riebman Jerome · CIK 0001825821 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,186 Underlying: Class A Common Stock · 10,186 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F3 · derivative.exercise_date: The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date. F3 · derivative.expiration_date: The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date. Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 00:28 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantStock Option (Right to Buy) · Derivative | 30,412 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001104659-20-113580 · a4.xml · derivative · entry 1 Riebman Jerome · CIK 0001825821 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,412 Underlying: Class A Common Stock · 30,412 shares Expires 2030-10-06 F1 · derivative.exercise_date: This option vests and becomes exercisable in 4 substantially equal annual installments on each of the successive years following October 7, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.